bcl-2 protein in non-small-cell lung carcinoma.
作者信息
Katz H R
出版信息
N Engl J Med. 1994 Jan 20;330(3):221. doi: 10.1056/NEJM199401203300321.
PMID:8264763
Abstract
摘要
相似文献
1
bcl-2 protein in non-small-cell lung carcinoma.
N Engl J Med. 1994 Jan 20;330(3):221. doi: 10.1056/NEJM199401203300321.
2
bcl-2 and prognosis in non-small-cell lung carcinoma.
N Engl J Med. 1994 Jun 16;330(24):1757-8.
3
High prevalence of bcl-2 oncoprotein expression in small cell lung cancer.小细胞肺癌中bcl-2癌蛋白表达的高发生率。
Anticancer Res. 1995 Mar-Apr;15(2):503-5.
4
bcl-2 protein in non-small-cell lung carcinoma.非小细胞肺癌中的bcl-2蛋白
N Engl J Med. 1993 Sep 2;329(10):690-4. doi: 10.1056/NEJM199309023291003.
5
Enhanced apoptosis predicts shortened survival in non-small cell lung carcinoma.增强的细胞凋亡预示非小细胞肺癌患者生存期缩短。
Cancer Res. 1995 Dec 1;55(23):5595-602.
6
Biological, molecular, and clinical markers for the diagnosis and typing of lung cancer.
Immunol Ser. 1990;53:453-68.
7
Expression of bcl-2 in small cell lung carcinoma cells.
Cancer Res. 1994 Jan 1;54(1):6-8.
8
9
Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma.在小细胞肺癌中FasL过表达的人类肺肿瘤中，Fas表达和功能频繁丧失。
J Pathol. 2003 Oct;201(2):268-77. doi: 10.1002/path.1428.
10
New challenges for laboratory diagnostics in non-small cell lung cancer.
Cancer Biomark. 2010;6(3-4):119-21. doi: 10.3233/CBM-2009-0123.
Zotero 插件